Latest Form 4 insider transactions

NASDAQ
Mitchell Lawrence Jones, See Remarks of Palisade Bio, Inc., reported multiple transactions in common stock on October 6, 2026.
NASDAQ
John David Finley, CEO CFO and a Director of Palisade Bio, Inc., reported multiple transactions in common stock on October 6, 2026.
Mitchell Young Williams, Chief Investment Officer and a Director of BioSig Technologies, Inc., sold 65,538 shares of common stock on October 1, 2026 for $0.54 per share.
Christine Marie Plummer, Chief Financial Officer of BioSig Technologies, Inc., sold 13,344 shares of common stock on August 1, 2026 for $0.54 per share.
NASDAQ
Ra Capital Management, L.P. and 3 others reported changes in beneficial ownership of Wave Life Sciences Ltd. common stock on October 5, 2026.
NASDAQ
Gregory L. Verdine, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Aik Na Tan, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Ken Takanashi, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Mark Corrigan, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Adrian Rawcliffe, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Heidi L Wagner, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Christian O Henry, a Director of Wave Life Sciences Ltd., reported multiple transactions in common stock on October 5, 2026.
NYSE
Ilaria Mocciaro, Chief Accounting Officer of Coherent Corp., reported multiple transactions in common stock on November 28, 2025.
NYSE
Joseph John Kaiser, a Director of MNTN, Inc., received 2,046 shares of common stock on October 5, 2026.
NASDAQ
Todd Krasnow, a Director of Symbotic Inc., sold 2,000 shares of common stock on October 5, 2026.
NYSE
Connor Kevin J O, a Director of Procore Technologies, Inc., sold 15,384 shares of common stock on October 5, 2026.
NYSE
Michelle Zatlyn, President and Board Co-Chair and a Director of Cloudflare, Inc., sold 99,009 shares of common stock on October 5, 2026.
NYSE
Shannon M Parisotto, CEVP, Disc & Safety Assessment of Charles River Laboratories International, Inc., sold 981 shares of common stock on October 5, 2026 for $308.44 per share.
NASDAQ
Richard L Clemmer, a Director of Skyworks Solutions, Inc., received 6,153 shares of common stock on October 5, 2026.
NYSE
Paul Diemer, a Director of SES AI Corp, received 320,000 shares of common stock on October 5, 2026.
NASDAQ
Robert A Bruggeworth, a Director of Skyworks Solutions, Inc., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Jason K Givens, SVP, Gen. Counsel & Secretary of Skyworks Solutions, Inc., reported multiple transactions in common stock on October 5, 2026.
NASDAQ
Denise Dignam, a Director of Kulicke & Soffa Industries Inc, received 493 shares of common stock on October 5, 2026.
NASDAQ
Gregory F Milzcik, a Director of Kulicke & Soffa Industries Inc, received 493 shares of common stock on October 5, 2026.
NASDAQ
Kristina Truong, Chief Accounting Officer of Enovix Corp, reported a transaction in 638 shares of common stock on October 6, 2026.
NASDAQ
Peter T M Kong, a Director of Kulicke & Soffa Industries Inc, received 493 shares of common stock on October 5, 2026.
NASDAQ
Jon A Olson, a Director of Kulicke & Soffa Industries Inc, received 493 shares of common stock on October 5, 2026.
NASDAQ
David Jeffrey Richardson, a Director of Kulicke & Soffa Industries Inc, received 493 shares of common stock on October 5, 2026.
NASDAQ
Mui Sung Yeo, a Director of Kulicke & Soffa Industries Inc, received 493 shares of common stock on October 5, 2026.
OQB
Tourism & Entertainment Group, LLC reported changes in beneficial ownership of StageWise Strategies Corp. common stock on October 5, 2026.